946125-65-1Relevant articles and documents
MEK INHIBITORS AND THERAPEUTIC USES THEREOF
-
Paragraph 0350, (2021/07/17)
The present disclosure provides compounds, compositions containing such compounds, and methods of designing, developing, producing and preparing compounds represented by general Formula (I), including pharmaceutically acceptable salts thereof or a synthetic intermediate thereof. The compounds act as MEK inhibitors and are capable of displaying one or more beneficial therapeutic effects, including treating cancer.
STING AGONISTS AND USES THEREOF
-
Paragraph 00620; 00839; 00942, (2020/07/14)
The present invention provides compounds, compositions thereof, and methods of using the same for the modulation of STING, and the treatment of STING-mediated disorders.
Benzoxazine compound and preparation method and application thereof
-
Paragraph 0095; 0099; 0129; 0130; 0131, (2017/10/07)
The invention discloses a benzoxazine compound, having a structure shown as in formula (I) that is shown in the description, or a pharmaceutically acceptable salt thereof; definitions of substituents in the formula (I) are shown in the description. In add